Abstract LB156: Identified the ISG15 mediated extracellular vesicles drives ovarian cancer progression and metastasis: extracellular vesicular ISG15 is a potential biomarker and therapeutic target
Kalpana Deepa Priya Dorayappan(The Ohio State University Wexner Medical Center), Selvendiran Karuppaiyah(The Ohio State University), Deepika Kalaiyarasan(The Ohio State University Wexner Medical Center), Qi‐En Wang(The Ohio State University), Meghan M. Newcomer(Case Western Reserve University), Wafa Khadraoui(University of Miami), Dongju Park(The Ohio State University Wexner Medical Center), Michelle DS Lightfoot(NYU Langone Health), Raphael E. Pollock(The University of Texas MD Anderson Cancer Center), Casey Cosgrove(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Larry J. Maxwell(Inova Fairfax Hospital), David E. Cohn(The Ohio State University), Vincent Wagner(The Ohio State University Wexner Medical Center), Takahiko Sakaue(Kurume University), David M. O’Malley(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 0
Related Papers
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
|Journal of the National Comprehensive Cancer Network|2019|332
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
|Annals of Surgery|2002|189
Soft Tissue Sarcoma
|Journal of the National Comprehensive Cancer Network|2010|167
Soft Tissue Sarcoma, Version 2.2012
|Journal of the National Comprehensive Cancer Network|2012|149